Why Illumina Stock Is Sinking Today
Shares of Illumina (NASDAQ: ILMN) were falling on Friday. The company's stock was down by as much as 11.4% early in the session, and was still off by 8.7% as of 2:38 p.m. ET. At that time, the S 500 had slid by 0.9% and the Nasdaq Composite was down 1.4%.
Illumina, a biotech company that develops and manufactures genetic testing systems, reported disappointing fourth-quarter numbers after the closing bell Thursday.
Illumina's revenue has stagnated or declined for several years now, and its total sales for 2024 were $4.3 billion, down from 2023's $4.5 billion. However, its bottom line was positive for the second quarter in a row in Q4, and its earnings of $0.95 per share beat expectations of $0.91 per share.
Source Fool.com
Illumina Inc. Stock
€162.62
-3.600%
With 18 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
With a target price of 179 € there is a slightly positive potential of 10.07% for Illumina Inc. compared to the current price of 162.62 €.
